| 摘要 |
The present invention relates to a pharmaceutical composition comprising a testosterone derivative having a log p of at least 5 and a vehicle, wherein the vehicle comprises a fat component in an amount sufficient to achieve lymphatic absorption in a mammal, wherein the fat component comprises a mono- or triglyceride of long chain fatty acids. |
